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httpPredictors of 30-day postoperative stroke or death
after carotid endarterectomy using the 2012 carotid
endarterectomy-targeted American College of
Surgeons National Surgical Quality Improvement
Program database
Kyla M. Bennett, MD, John E. Scarborough, MD, and Cynthia K. Shortell, MD, Durham, NC
Objective: This study used a recently released procedure-targeted multicenter data source to determine independent
predictors of postoperative stroke or death in patients undergoing carotid endarterectomy (CEA) for carotid artery
stenosis.
Methods: The 2012 CEA-targeted American College of Surgeons (ACS) National Surgical Quality Improvement Program
(NSQIP) database was used for this study. Patient, disease, and procedure characteristics of patients undergoing CEA
were assessed. Multivariate logistic regression analysis was used to determine independent risk factors for 30-day post-
operative stroke/death or other major complications.
Results: The analysis included 3845 patients undergoing CEA (58.1% with asymptomatic and 41.9% with symptomatic
carotid disease). The overall 30-day postoperative stroke/death rate was 3.0% (1.9% in asymptomatic patients, 4.6% in
symptomatic patients). The variables that maintained an independent association with postoperative stroke/death after
adjustment for other known patient-related and procedure-related factors were age $80 years, active smoking, contra-
lateral internal carotid artery stenosis of 80% to 99%, emergency procedure status, preoperative stroke, presence of one or
more ACS NSQIP-deﬁned high-risk characteristics (including any or all of New York Heart Association class III/IV
congestive heart failure, left ventricular ejection fraction <30%, recent unstable angina, or recent myocardial infarction),
and operative time $150 minutes.
Conclusions: After adjustment for a comprehensive array of patient-related and procedure-related variables of particular
import to patients with carotid artery stenosis, we have identiﬁed several factors that are independently associated with
early stroke or death after CEA. These factors are generally related to the comorbid condition of CEA patients and to
speciﬁc characteristics of their carotid disease, and not to technical features of the CEA procedure. Knowledge of these
factors will assist surgeons in selecting appropriate patients for this procedure. (J Vasc Surg 2015;61:103-11.)Perioperative risk has long been recognized as an
important determinant of a patient’s suitability for carotid
endarterectomy (CEA). Although landmark trials per-
formed in the 1990s appeared to establish the degree of
stenosis beyond which CEA proved superior to medical
therapy for long-term stroke prevention, the conclusions
drawn from these trials assumed an incidence of early post-
operative stroke or death that was lower than might be
achievable outside of the clinical trial setting.1-6 Moreover,
improved medical therapy for carotid artery atherosclerosis
and increased use of carotid artery stenting have expanded
the array of potentially effective treatment options that are
available to patients with hemodynamically signiﬁcantthe Department of Surgery, Duke University Medical Center.
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now reasonable to expect that CEA be performed only
when the anticipated risk of perioperative stroke or death
is sufﬁciently low.7-13
Given this impetus for preoperative risk assessment in
patients with carotid stenosis, a number of studies have
attempted to identify the factors that are associated with
early post-CEA stroke or death and might therefore pre-
clude surgical intervention.14-27 However, most of these
studies carry important limitations, the most pervasive be-
ing a failure to reliably adjust for disease-speciﬁc and
procedure-speciﬁc variables that are of particular relevance
to the potential outcomes of patients undergoing
CEA.14,16,18-20,22,24-27
The recently developed CEA-targeted American Col-
lege of Surgeons (ACS) National Surgical Quality
Improvement Program (NSQIP) database offers a unique
opportunity to address this deﬁciency in our knowledge
of potential predictors of postoperative stroke or death af-
ter CEA. Similar to the more generalized multispecialty
ACS NSQIP database, information contained within
the CEA-targeted database is prospectively collected by
trained clinical viewers and is subject to periodic auditing
to ensure reliability and accuracy.28 Unlike its multispecialty103
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information about 22 additional variables that are of speciﬁc
concern in patients with carotid artery disease who undergo
CEA, including details about preoperative symptoms, the
degree of ipsilateral and contralateral carotid stenosis, and
the use of various preoperative pharmacologic and intraoper-
ative technical adjuncts.29 These qualities make this data set
unique in its potential ability to discern which preoperative
factors place a patient at greatest risk for poor outcome after
CEA and which intraoperative factors might abate or exac-
erbate that risk.
The objective of our study was therefore to use data
from the 2012 CEA-targeted ACS NSQIP database to
identify patient-speciﬁc, disease-speciﬁc, or procedure-
speciﬁc variables that are independently associated with
increased risk of stroke or death after CEA. We anticipate
that the results of our analysis may inform decisions
regarding optimal management of patients with carotid ar-
tery disease.
METHODS
The 2012 ACS-NSQIP CEA-targeted Participant User
File (PUF) contains information about 22 procedure-
speciﬁc variables for CEA procedures performed at 78
different centers within the United States.29 Additional in-
formation about each patient included in our study sample
was obtained by merging the CEA-targeted data set with
the larger and more generalized 2012 general and vascular
surgery ACS-NSQIP PUF, which includes more general
information about the patients from the CEA-targeted
data set, including demographic information, other comor-
bid conditions, and 30-day postoperative mortality and
morbidity.
The data contained within both data sets are collected
by ACS-trained and certiﬁed clinical reviewers who obtain
information for each patient using a variety of methods,
including medical record abstraction. The reviewers use
strict variable deﬁnitions when collecting data to ensure
uniformity across participating centers, and periodic audit-
ing of participating centers is performed to ensure that the
data contained within the database is accurate.28
Our study sample comprised all patients from the 2012
ACS-NSQIP CEA-targeted PUF who had complete infor-
mation for the variables included in our analysis. Data for
two variables, patient race/ethnicity and degree of contra-
lateral internal carotid artery (ICA) stenosis, were missing
or unknown in a nontrivial percentage of patients. There-
fore, rather than excluding patients with missing data for
either of these variables, we instead created a multilevel
classiﬁcation schema for the two variables that included
“unknown” as a potential category.
The primary outcome for our analysis was the 30-day
combined incidence of stroke or death. The CEA-
targeted ACS NSQIP database deﬁnes postoperative stroke
as “the acute neurologic injury that occurs as a result of
brain ischemia or infarction [on the] same side of the brain
as the carotid procedure,” and considers patients to have
sustained a postoperative stroke if they were documentedto have typical signs and symptoms or new radiologic ﬁnd-
ings consistent with a stroke in the 30 days after their CEA
procedure.29
Secondary outcomes included the 30-day combined
postoperative incidence of nonstroke major morbidity,
including myocardial infarction, new cardiac arrhythmia,
pneumonia, mechanical ventilation requirement for
>48 hours, pulmonary embolism, deep venous throm-
bosis, acute renal failure requiring dialysis, cardiopulmo-
nary arrest, bleeding requiring transfusion of 4 or more
units of packed red blood cells within the ﬁrst 72 hours
postoperatively, or septic shock.
Potential predictor variables included patient age (<70,
70-79, or$80 years), gender, race/ethnicity (white, other,
or unknown), body mass index (<20, 20-24.9, 25-29.9, or
$30 kg/m2), diabetes mellitus (none, no insulin required,
or insulin required), ongoing tobacco use, chronic obstruc-
tive pulmonary disease, end-stage renal disease, chronic ste-
roid usage, bleeding disorder, functional health status
(independent or partially/completely dependent on others
for activities of daily living), American Society of Anesthe-
siologists (ASA) Physical Status Classiﬁcation (class 1-3 or
class 4-5), presence of one or more Centers for Medicare
and Medicaid Services (CMS)-deﬁned physiologic high-
risk factors (including any or all of New York Heart Asso-
ciation class III/IV congestive heart failure, left ventricular
ejection fraction <30%, unstable angina #30 days before
surgery, or myocardial infarction in the 30 days before sur-
gery30), presence of one or more anatomic high-risk factors
(including any or all of a prior ipsilateral CEA or carotid ar-
tery stenting, prior ipsilateral neck dissection, contralateral
carotid arterial occlusion, prior radiation to the neck, or
contralateral laryngeal nerve injury or palsy), preoperative
antiplatelet medication usage, preoperative statin usage,
preoperative b-blocker usage, degree of ipsilateral ICA ste-
nosis as determined by preoperative Doppler ultrasound
imaging, computed tomography angiogram, or magnetic
resonance angiogram (<50%, 50%-79%, 80%-99%, or oc-
clusion), degree of contralateral ICA stenosis (<50%,
50%-79%, 80%-99%, occluded, or not checked/missing),
emergency procedure status, surgeon specialty (vascular
surgeon or nonvascular surgeon), anesthesia modality
(general or locoregional), intraoperative use of patch an-
gioplasty, intraoperative use of a carotid artery shunt (yes,
no), eversion technique, and operation duration
(<90 minutes, 90-119 minutes, 120-149 minutes, or
$150 minutes).
For our analysis of primary outcomes (combined 30-
day postoperative stroke/death rate), we stratiﬁed patients
into separate asymptomatic and symptomatic groups,
which included any patient with ipsilateral symptoms
such as transient ischemic attack (TIA), amaurosis fugax,
transient monocular blindness, or stroke. We did not strat-
ify patients by preoperative symptomatology for our anal-
ysis of secondary outcomes (30-day nonstroke major
morbidity rate). The univariate association between poten-
tial predictor variables and 30-day primary or secondary
outcomes were ﬁrst assessed using Pearson c2 tests. Only
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the outcome of interest at the P < .25 level were included
as a predictor variable in multivariate analysis.
Three multivariate models were considered: one to
determine the independent predictors of stroke/death in
asymptomatic patients, one to determine the independent
predictors of stroke/death in symptomatic patients, and
one to determine the independent predictors of nonstroke
major morbidity in all patients from our study sample. For
the model used to determine predictors of stroke/death in
symptomatic patients, preoperative symptom type was also
considered as a potential predictor variable (classiﬁed as
amaurosis fugax/TIA or stroke). This variable was also
considered as a potential predictor in the model used to
determine predictors of nonstroke major morbidity in all
patients, with patients being classiﬁed as asymptomatic,
amaurosis fugax/TIA, or stroke. In addition, we also
repeated the aforementioned multivariate regression
models after forcing in the “race” and “degree of contralat-
eral stenosis” variables because data for these variables were
missing in a substantial number of patients in our sample.
These multivariate models were then used to calculate
adjusted odds ratios and 95% conﬁdence intervals for each
potential predictor of the outcome of interest. The
adjusted odds ratio and 95% conﬁdence intervals was re-
ported for each predictor variable found to have an inde-
pendent association with that respective outcomes at the
P < .05 level. The C statistic and Hosmer-Lemeshow sta-
tistic were reported for each of these two multivariate
regression models. Those predictor variables that had an in-
dependent association with postoperative stroke or death
were used to create separate risk models for asymptomatic
and symptomatic patients undergoing CEA, in which the
expected risk of stroke or death, as determined from our
study sample, was stratiﬁed by the number of risk factors
present. STATA 11 software (StataCorp LP, College Sta-
tion, Tex) was used for all statistical analyses.
RESULTS
The analysis included 3845 patients undergoing CEA
(58.2% asymptomatic, 41.9% symptomatic). The character-
istics of asymptomatic patients and the procedures they
received are reported in Table I. Several factors exhibited
a univariate association with 30-day postoperative stroke
or death at the P < .05 level in asymptomatic patients,
including active tobacco use, presence of a bleeding disor-
der, nonindependent functional health status, ASA class 4
or 5, and operative duration.
The characteristics of symptomatic patients and their
procedures are reported in Table II. Variables that dis-
played a univariate association with 30-day postoperative
stroke or death in these patients included preoperative
symptom type, the presence of one or more physiologic
high-risk factors, the degree of contralateral ICA stenosis,
and emergency procedure status.
Several other factors exhibited a univariate association
with 30-day postoperative stroke or death in asymptomatic
or symptomatic patients at the P ¼ .05 to .25 level andwere therefore included as potential predictor variables in
the respective multivariate logistic regression models that
were used to identify independent risk factors for stroke/
death in these two patient groups. Excepting operative
time and use of patch angioplasty, none of the intraopera-
tive factors captured in the CEA-targeted ACS NSQIP data
set displayed a univariate association with postoperative
stroke or death below the P < .25 level in asymptomatic
or symptomatic patients. These factors were therefore not
included as potential predictor variables in the subsequent
multivariate regression models.
The overall 30-day postoperative combined incidence
of stroke or death after CEA was 3.0% (1.9% in asymptom-
atic patients, 4.6% in symptomatic patients). Independent
predictors of this outcome in asymptomatic patients are
summarized in Table III, and include ASA class 4 or 5,
and 80% to 99% contralateral ICA stenosis. Independent
predictors of postoperative stroke or death in symptomatic
patients are reported in Table IV, and include emergency
procedure status, the presence of one or more ACS
NSQIP-deﬁned physiologic high-risk characteristics, pre-
operative stroke (vs TIA or amaurosis fugax), and 80% to
99% contralateral ICA stenosis.
The C statistics for the multivariate logistic regression
models that were used to identify these predictors were
0.7397 for the asymptomatic group and 0.6997 for the
symptomatic group (indicating reasonable discrimination),
and the Hosmer-Lemeshow statistics were 8.07 (P ¼
.4266) for the asymptomatic group and 9.05 (P ¼
.3382) for the symptomatic group, indicative of excellent
goodness-of-ﬁt. Of note, the inclusion of race (due to its
relatively high proportion of unknown values) as a forced
predictor variable in these multivariate models did not alter
the general conclusions drawn from these models. Fig, a
demonstrates the expected risk of 30-day postoperative
stroke/death for asymptomatic patients undergoing CEA,
based on the number of independent risk factors for this
outcome that they exhibited. Fig, b demonstrates the ex-
pected risk of 30-day postoperative stroke/death for symp-
tomatic patients, also stratiﬁed by the number of
independent risk factors present.
The overall 30-day incidence of nonstroke major
morbidity was 5.3% (204 of 3845 patients), and the speciﬁc
incidence of myocardial infarction or new cardiac
arrhythmia, or both, was 2.1%. Independent predictors of
nonstroke major morbidity, drawn from a multivariate
regression model that included asymptomatic and symp-
tomatic patients, are reported in Table V and include
advanced age, the presence of one or more high-risk
anatomic factors, diabetes mellitus requiring insulin, and
operative time $150 minutes. The C statistic for the
regression model used to identify predictors of nonstroke
morbidity was 0.7355, and the Hosmer-Lemeshow statistic
was 3.87 (P ¼ .8688).
DISCUSSION
In this study, we describe postoperative outcomes for
3845 patients included in the recently released 2012 ACS
Table I. Patient, disease, and procedure characteristics of
patients undergoing carotid endarterectomy (CEA) for
asymptomatic carotid stenosis and their univariate
association with 30-day combined postoperative stroke or
death rate
Characteristic
Patients
(n ¼ 2236),
No. (%)
30-day death/
stroke rate
(n ¼ 43 [1.9%]),
% P
Age, years .36
<70 864 (38.6) 2.20
70-79 911 (40.7) 1.40
$80 461 (20.6) 2.40
Gender .61
Male 1333 (59.6) 1.80
Female 903 (40.4) 2.10
Race .7
White 1982 (88.6) 1.90
Other 156 (7.0) 1.90
Missing 98 (4.4) 3.10
Body mass index, kg/m2 .5
<20 77 (3.4) 3.90
20-24.9 500 (22.4) 1.40
25-29.9 893 (39.9) 2.00
$30 766 (34.3) 2.00
Diabetes mellitus .37
None 1544 (69.1) 1.70
Noninsulin 455 (20.4) 2.20
Insulin 237 (10.6) 3.00
Ongoing tobacco use .03
No 1708 (76.4) 1.60
Yes 528 (23.6) 3.00
COPD .07
No 2008 (89.8) 1.70
Yes 228 (10.2) 3.50
End-stage renal disease .6
No 2205 (98.6) 1.90
Yes 31 (1.4) 3.20
Chronic steroid use .24
No 2168 (97.0) 2.00
Yes 68 (3.0) 0
Bleeding disorder .02
No 1864 (83.4) 1.60
Yes 372 (16.6) 3.50
Functional health status .11
Independent 2200 (98.4) 1.90
Nonindependent 36 (1.6) 5.60
ASA Physical Status Classiﬁcation <.001
1-3 1941 (86.8) 1.50
4-5 295 (13.2) 4.80
Physiologic high-risk factors .08
No 2120 (95.9) 1.80
Yes 91 (4.1) 4.40
Anatomic high-risk factors .25
No 1968 (89.1) 1.80
Yes 241 (10.9) 2.90
Preoperative medication use
Antiplatelet .78
No 280 (12.6) 2.10
Yes 1947 (87.4) 1.90
Statin .29
No 456 (20.5) 1.30
Yes 1772 (79.5) 2.10
b-blocker .32
No 941 (42.3) 1.60
Yes 1284 (57.7) 2.20
(Continued)
Table I. Continued.
Characteristic
Patients
(n ¼ 2236),
No. (%)
30-day death/
stroke rate
(n ¼ 43 [1.9%]),
% P
Degree of ICA stenosis, %
Ipsilateral .79
<50 15 (0.7) 0
50-79 565 (25.3) 1.60
80-99 1643 (73.5) 2.10
Occlusion 13 (0.6) 0
Contralateral .07
<50 1115 (49.9) 1.40
50-79 658 (29.4) 2.10
80-99 117 (5.2) 5.10
Occlusion 96 (4.3) 3.10
Not checked/missing 250 (11.2) 1.60
Emergency procedure .75
No 2231 (99.8) 1.90
Yes 5 (0.3) 0
Surgeon specialty .97
Vascular 2135 (95.5) 1.90
Nonvascular 101 (4.5) 2.00
Anesthesia .68
General 1872 (83.7) 2.00
Locoregional 364 (16.3) 1.70
Patch angioplasty .12
No 475 (21.2) 1.10
Yes 1761 (78.8) 2.20
Intraoperative shunt placement .54
No 1368 (61.2) 1.70
Yes 713 (31.9) 2.40
Unknown (eversion) 155 (6.9) 1.90
Eversion .99
No 2.081 (93.1) 1.90
Yes 155 (6.9) 1.90
Operative duration, min .02
<90 624 (27.9) 1.10
90-119 656 (29.3) 1.20
120-149 510 (22.8) 3.30
$150 446 (20.0) 2.50
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; ICA, internal carotid artery.
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stroke/death rate was 3.0% for the overall study sample
(1.9% for asymptomatic patients and 4.6% for symptomatic
patients). Of importance is whether these outcomes are
generalizable to everyday surgical practice. Although the
speciﬁc characteristics of the 78 centers that contributed in-
formation to our data source have not yet been published,
the overall 30-day stroke/death rate of 3.0% achieved by
these centers is within the 1.8% to 5.2% event range re-
ported for other multicenter data sources that track 30-
day outcomes and include symptomatic and asymptomatic
patients.
Using multivariate logistic regression, we have identi-
ﬁed two variables that maintained an independent associa-
tion with the incidence of 30-day postoperative stroke/
death in asymptomatic patients and four variables that
maintained an independent association with this primary
outcome in symptomatic patients. Surgeons can use these
Table II. Patient, disease, and procedure characteristics
of patients undergoing carotid endarterectomy (CEA) for
symptomatic carotid stenosis and their univariate
association with 30-day combined postoperative stroke or
death rate
Characteristic
Patients
(n ¼ 1609),
No. (%)
30-day death/
stroke rate
(n ¼ 74 [4.6%]),
% P
Age, years .37
<70 684 (42.5) 4.00
70-79 567 (35.2) 4.60
$80 358 (22.3) 5.90
Gender .55
Male 1013 (63.0) 4.80
Female 596 (37.0) 4.20
Race .46
White 1361 (84.6) 4.30
Other 138 (8.6) 6.50
Missing 110 (6.8) 5.50
Body mass index, kg/m2 .99
<20 58 (3.6) 5.20
20-24.9 415 (25.8) 4.60
25-29.9 625 (38.8) 4.60
$30 511 (31.8) 4.50
Diabetes mellitus .71
None 1147 (71.3) 4.50
Noninsulin 271 (16.8) 5.50
Insulin 191 (11.9) 4.20
Ongoing tobacco use .14
No 1144 (71.1) 4.10
Yes 465 (28.9) 5.80
COPD .64
No 1430 (88.9) 4.70
Yes 179 (11.1) 3.90
End-stage renal disease .36
No 1592 (98.9) 4.70
Yes 17 (1.1) 0
Chronic steroid use .77
No 1556 (96.7) 4.60
Yes 53 (3.3) 3.80
Bleeding disorder .58
No 1176 (73.1) 4.40
Yes 433 (26.9) 5.10
Functional health status .17
Independent 1532 (95.2) 4.40
Not independent 77 (4.8) 7.80
ASA Physical Status Classiﬁcation .8
1-3 1301 (80.9) 4.50
4-5 308 (19.1) 4.90
Preoperative symptoms .003
TIA/amaurosis fugax 922 (57.3) 3.30
Stroke 687 (42.7) 6.40
Physiologic high-risk factors .02
No 1514 (95.6) 4.00
Yes 70 (4.4) 10.00
Anatomic high-risk factors .2
No 1382 (87.0) 4.30
Yes 207 (13.0) 6.30
Preoperative medication use
Antiplatelet .2
No 193 (12.1) 6.20
Yes 1402 (87.9) 4.20
Statin .68
No 759 (47.8) 4.20
Yes 830 (52.2) 4.70
(Continued)
Table II. Continued.
Characteristic
Patients
(n ¼ 1609),
No. (%)
30-day death/
stroke rate
(n ¼ 74 [4.6%]),
% P
b-blocker .93
No 1700 (44.6) 4.60
Yes 2114 (55.4) 4.70
Degree if ICA stenosis, %
Ipsilateral .82
<50 29 (1.8) 6.90
50-79 593 (36.9) 4.10
80-99 969 (60.2) 4.90
Occlusion 18 (1.1) 5.60
Contralateral .001
<50 857 (53.3) 3.20
50-79 400 (24.9) 5.00
80-99 125 (7.8) 11.20
Occlusion 60 (3.7) 8.30
Not checked/missing 167 (10.4) 4.80
Emergency procedure .002
No 1544 (96.0) 4.30
Yes 65 (4.0) 12.30
Surgeon specialty .96
Vascular 1481 (92.0) 4.60
Nonvascular 128 (8.0) 4.70
Anesthesia .55
General 1406 (87.4) 4.50
Locoregional 203 (12.6) 5.40
Patch angioplasty .82
No 365 (22.7) 4.40
Yes 1244 (77.3) 4.70
Intraoperative shunt placement .34
No 982 (61.0) 4.40
Yes 535 (33.3) 5.40
Unknown (eversion) 92 (5.7) 2.20
Eversion .25
No 1517 (94.3) 4.80
Yes 92 (5.7) 2.20
Operative duration, min .45
<90 428 (26.6) 4.00
90-119 406 (25.2) 5.20
120-149 368 (22.9) 3.50
$150 407 (25.3) 5.70
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; ICA, internal carotid artery; TIA, transient ischemic
attack.
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risk for adverse events after CEA. For example, the inci-
dence of postoperative stroke/death was 5.3% for asymp-
tomatic patients in our sample who exhibited either one
of the independent risk factors for postoperative stroke/
death, which surpasses the 3.0% event rate currently recom-
mended by the Society for Vascular Surgery as the upper
threshold for acceptable risk in asymptomatic patients.13
Similarly, symptomatic patients in our sample with one or
two risk factors demonstrated a postoperative stroke/death
rate in excess of the 6.0% threshold deﬁned as acceptable by
the recently published 2011 American Stroke Association/
American College of Cardiology Foundation guidelines.12
Although the risk model has yet to be externally validated,
Table IV. Independent predictors of 30-day
postoperative stroke or death after carotid
endarterectomy (CEA) for symptomatic carotid stenosis
Characteristic
AORa (95% CI) of
30-day postoperative
stroke or death P
Contralateral ICA stenosis
80%-99% (Ref: <50% stenosis)
3.60 (1.73-7.45) .001
Emergency procedure 3.24 (1.38-7.61) .007
Physiologic high-risk characteristic 2.47 (1.03-5.96) .04
Preoperative stroke
(Ref: amaurosis fugax/TIA)
1.74 (1.05-2.89) .03
AOR, Adjusted odds ratio; CI, conﬁdence interval; ICA, internal carotid
artery; Ref, reference; TIA, transient ischemic attack.
aAdjusting for patient-related, disease-related, and procedure-related vari-
ables that demonstrated a univariate association with 30-day postoperative
stroke or death at the P < .25 level.
Table III. Independent predictors of 30-day
postoperative stroke or death after carotid
endarterectomy (CEA) for asymptomatic carotid stenosis
Characteristic
AORa (95% CI) of
30-day postoperative
stroke or death P
Contralateral ICA stenosis
80%-99% (Ref: <50% stenosis)
3.10 (1.16-8.26) .02
ASA Physical Status Classiﬁcation 4 or 5 2.29 (1.14-4.59) .02
AOR, Adjusted odds ratio; ASA, American Society of Anesthesiologists; CI,
conﬁdence interval; ICA, internal carotid artery; Ref, reference.
aAdjusting for patient-related, disease-related, and procedure-related vari-
ables that demonstrated a univariate association with 30-day postoperative
stroke or death at the P < .25 level.
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perioperative stroke/death risk in prospective CEA
candidates.
Few other published studies have included patient-
related, disease-related, and procedure-related factors
when assessing potential predictors of stroke or death after
CEA. Kragsterman et al21 analyzed the outcomes of 1518
patients undergoing CEA at one of 20 Swedish hospitals
from 1994 to 1996, 4.3% of whom sustained a stroke or
died #30 days after the operation. Predictors of this
outcome included performance of the procedure at a uni-
versity hospital, preoperative stroke, diabetes mellitus,
and preoperative cardiac disease. To determine the poten-
tial effect of disease-related and procedure-related factors
on CEA outcomes, the authors then performed a case-
control analysis comparing 65 patients with postoperative
stroke/death vs 130 controls who were matched for hospi-
tal type, preoperative symptom status, and age. The only
factor to differ signiﬁcantly between the two matched
groups was the percentage of patients with contralateral ca-
rotid occlusion, which was higher in the group that sus-
tained postoperative stroke or death. The two groups did
not differ signiﬁcantly in degree of ipsilateral stenosis, intra-
operative volume of blood loss, carotid shunt use, carotid
occlusion time, operative time, anesthesia modality, or
use of tacking sutures at the distal endarterectomy site.21
Hannan et al17 performed a separate analysis of 3644
patients undergoing CEA at one of 37 hospitals in New
York state. The in-hospital postoperative stroke/death
rate for this cohort was 1.84%. Signiﬁcant predictors of
stroke/death on univariate analysis were hypertension, car-
diac valve disease, diabetes mellitus, preoperative atrial
ﬁbrillation, symptomatic carotid disease, contralateral ca-
rotid occlusion, and degree of ICA stenosis. The authors
included these seven variables in a separate risk adjustment
model to determine the effect of intraoperative factors on
the incidence of postoperative stroke/death and found
that the use of one or more speciﬁc adjuncts during CEAd
protamine, shunting, and carotid eversiondresulted in a
signiﬁcant reduction in the risk of adverse postoperative
outcomes.17 Interestingly, none of these three adjuncts
maintained an independent relationship with postoperativestroke/death when considered separately. In addition, no
association was found between the intraoperative use of
heparin or the use of a patch graft and postoperative
stroke/death rate.
Wong et al15 also examined the outcomes of 291 CEA
patients from four Canadian hospitals. The 30-day stroke/
death rate for these patients was 5.2% and was predicted by
preoperative angina, congestive heart failure, and failure to
use antiplatelet medications. No association was found be-
tween the stroke/death rate and carotid plaque character-
istics, intraoperative shunt use, or surgeon specialty.
To our knowledge, only one published study of CEA
risk factors has been able to draw from a pool of potential
predictor variables as comprehensive as is now available
from the CEA-targeted ACS NSQIP database. Goodney
et al23 analyzed 3092 CEA procedures from the 2003 to
2007 Vascular Study Group of Northern New England, a
regional quality improvement initiative involving 11 cen-
ters. The authors were able to adjust for most of the
disease-speciﬁc and procedure-speciﬁc variables that are
currently included in the CEA-targeted ACS NSQIP data
set, with the exception of operative time. The overall inci-
dence of 30-day postoperative stroke/death in their study
was 1.8%. Age >70 years, symptomatic carotid disease,
contralateral carotid occlusion, congestive heart failure,
and emergency procedure status were each associated
with an increased risk of stroke/death after CEA, whereas
preoperative administration of antiplatelet medications was
associated with a decreased risk of this outcome. Of note,
the authors adjusted only for the presence or absence of
contralateral carotid occlusion, not for different degrees
of contralateral stenosis. Intraoperative variables that failed
to predict the risk of postoperative stroke or death included
anesthesia modality, intraoperative shunting, eversion end-
arterectomy, and patch angioplasty.
Their ﬁndings support the results of our own analysis,
which suggest that perioperative risk during CEA largely
depends on patient and disease characteristics. The only
technical factor in our analysis that demonstrated an inde-
pendent association with postoperative stroke/death rate
Fig. Expected risk of 30-day postoperative stroke/death for (a) asymptomatic patients and (b) symptomatic patients
undergoing carotid endarterectomy (CEA), stratiﬁed by number of risk factors present.
JOURNAL OF VASCULAR SURGERY
Volume 61, Number 1 Bennett et al 109on univariate analysis was prolonged operative time (and
only for asymptomatic patients). Although this variable
may simply serve as a marker for some other patient or dis-
ease characteristic that makes CEA technically more
difﬁcult to perform, its potential association with postoper-
ative outcomes should nevertheless highlight the potential
importance of expeditious technical conduct during CEA
procedures.
Our ﬁnding with respect to the importance of the four
NSQIP-deﬁned physiologic high-risk conditions in deter-
mining stroke/death risk after CEA in symptomatic pa-
tients deserves special attention. These and four other
factors (including age >80 years, renal failure, severe
chronic lung disease, and requirement for aortocoronary
bypass or cardiac valve surgery #30 days) are currentlyconsidered by the CMS to place patients at high risk for
adverse outcomes after CEA and are therefore used as
criteria to determine eligibility for reimbursement of ca-
rotid artery stenting procedures.30,31 Our analyses were
able to adjust for seven of these eight criteria (three individ-
ually and four as a composite variable). Although we did
not ﬁnd an association between renal failure or chronic
obstructive pulmonary disease and the incidence of postop-
erative stroke or death in the asymptomatic or symptomatic
groups of our study, and although our analysis is not equip-
ped to address whether stenting is a more suitable option
in patients with the other CMS “high-risk” conditions,
our ﬁndings conﬁrm the negative effect of these other con-
ditions on post-CEA outcomes in patients with symptom-
atic disease.
Table V. Independent predictors of 30-day postoperative major morbidity after carotid endarterectomy (CEA)
Characteristic AORa (95% CI) of 30-day postoperative major morbidity P
Nonindependent functional health status 2.94 (1.68-5.15) <.001
Operative time $150 min (Ref: <90 min) 2.88 (1.83-4.54) <.001
Age $80 years (Ref: age <70 years) 2.48 (1.70-3.62) <.001
ASA Physical Status Classiﬁcation 4 or 5 (Ref: class 1-3) 1.81 (1.29-2.55) .001
Bleeding disorder 1.74 (1.26-2.40) .001
Anatomic high-risk factor 1.58 (1.04-2.39) .03
Insulin-dependent diabetes mellitus (Ref: no diabetes) 1.54 (1.02-2.34) .04
Preoperative b-blocker use 1.45 (1.05-2.00) .03
AOR, Adjusted odds ratio; ASA, American Society of Anesthesiologists; CI, conﬁdence interval; Ref, reference.
aAdjusting for variables that had a univariate association with major postoperative morbidity at the P < .25 level: age, race/ethnicity, diabetes classiﬁcation,
end-stage renal disease, chronic steroid use, bleeding disorder, functional health status, ASA Physical Status Classiﬁcation, physiologic high-risk factors,
anatomic high-risk factors, preoperative b-blockade, degree of contralateral internal carotid artery (ICA) stenosis, emergency procedure status, anesthesia
modality, intraoperative shunt classiﬁcation, use of eversion technique, and operative time.
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information contained within the ACS NSQIP PUFs
does not contain surgeon or hospital identiﬁers. We are
therefore unable to adjust for the potential effect that sur-
geon and hospital procedure volume might have on early
outcomes after CEA.32,33
Second, although the sample size in our study is com-
parable with that of other studies that have used similar
data sources, the number of actual postoperative stroke/
death events is small. As a result, our conclusions that
some variables are not independently associated with
postoperative stroke or death may be subject to type II er-
ror. However, as centers continue to contribute informa-
tion to the CEA-targeted ACS NSQIP database over the
next few years, the power of this data source to detect
other independent predictors of poor post-CEA outcomes
will increase. At the very least, our analysis of the ﬁrst
year’s release of data from CEA-targeted ACS NSQIP
has demonstrated those variables that have the clearest
and strongest association with postoperative stroke or
death.
Third, because of the manner in which data is collected
in ACS NSQIP, we were only able to consider four of the
previously mentioned CMS high-risk conditions as one
composite variable instead of as four discrete variables.
We therefore cannot determine the individual association
that each of these conditions may have on postoperative
outcomes.
Finally, ACS NSQIP does not contain information
about patient outcomes >30 postoperative days. As a
result, we are unable to draw conclusions on the potential
effects of CEA on long-term stroke prevention or survival.
CONCLUSIONS
Despite these limitations, our study provides the pub-
lished description of outcomes from the recently released
2012 CEA-targeted ACS NSQIP database. From the
wide array of patient, disease, and procedure characteristics
that are tracked by this data source, we have identiﬁed
two in asymptomatic patients and four in symptomatic pa-
tients that are independently associated with an increasedincidence of early stroke or death after CEA. Knowledge
of these risk factors can assist surgeons in identifying those
patients with critical carotid artery stenosis who are accept-
able candidates for CEA. As the number of patients
included in the CEA-targeted version of ACS NSQIP
grows in future years, the power of this data source to assist
surgeons in practical risk assessment should continue to in-
crease. Whether subsequent analyses will demonstrate that
the CEA technique exhibits a signiﬁcant effect on postop-
erative outcomes remains to be seen. At present, our initial
analysis of this unique data set suggests that patient and dis-
ease characteristics are more important than intraoperative
technical conduct in determining a patient’s risk of stroke
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